Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists

PURPOSE: This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. PRINCIPAL RESULTS: 92% of responding neurologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Shawheen J., Vogel, Andre C., Gazdag, Brittany, Alakel, Nicholas, Kumar, Aditya Ravi, Mateen, Farrah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351672/
https://www.ncbi.nlm.nih.gov/pubmed/32682142
http://dx.doi.org/10.1016/j.jneuroim.2020.577320
Descripción
Sumario:PURPOSE: This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. PRINCIPAL RESULTS: 92% of responding neurologists considered their NMO patients to be at an elevated risk of acquiring Covid19. They also indicated sharp declines in visits, delays in treatment and related services, and several unmet needs deterring treatment. MAJOR CONCLUSIONS: There is a need for evidence-based, comprehensive guidelines for treating NMO patients amid healthcare crises moving forward.

Ejemplares similares